Moderna 1 juin 2026 Moderna and CEPI expand collab to include Bundibugyo ebolavirus vaccine - The Pharma Letter
Promega Blog 1 juin 2026 Advancing Canine Cancer Immunotherapy through One Health Comparative Oncology Research
Endpoints News 1 juin 2026 After being ditched by Candid, Rallybio finds Avenzo to take its Nasdaq listing
FierceBiotech 1 juin 2026 Rallybio swerves past Candid pothole to land deal with cancer drug developer Avenzo
FierceBiotech 1 juin 2026 Agios signs $165M deal for blood disorder drug from Korea’s Oscotec that flunked phase 2 study
FierceBiotech 1 juin 2026 Servier inks $2.6B buyout of Edgewise’s muscular dystrophy unit to beef up neurology pipeline
Illumina 1 juin 2026 Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights - Business Wire
Endpoints News 1 juin 2026 Servier signs $1.55B upfront deal for Edgewise's muscular dystrophy assets
Thermo Fisher 1 juin 2026 Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - The Joplin Globe